Skip to main content

Interventional Ultrasound: Biopsy of Renal Masses

  • Chapter
  • First Online:
  • 2019 Accesses

Abstract

An increasing number of renal masses with heterogeneous histology and clinical behaviour are being detected with modern radiological imaging. Purpose of this chapter is to provide an analysis of the rationale, indications, technique, safety and outcomes of percutaneous needle core biopsies of renal tumours. Renal tumour biopsies can be performed under ultrasound or CT guidance with local anaesthesia in the majority of cases. Core biopsies using 18G needles with a coaxial technique should be favoured to sample solid renal masses. With the use of modern techniques biopsies are safe, with limited risk of significant bleeding and virtually no risk of tumour seeding. Both diagnostic yield and accuracy for tumor malignancy and histotype are good in centres with expertise. Renal tumor biopsies should be increasingly performed in the diagnostic work-up of renal masses that are indeterminate at imaging, for the histological characterization of small renal masses in patients who are candidates for non surgical management in order to support treatment decisions, after thermal ablation in order to confirm histological success and monitor for recurrence, and in metastatic tumors when a cytoreductive nephrectomy is not indicated in order to select the best suited targeted therapy. Well designed, prospective, large studies are needed to define optimal and standardised patterns of biopsy and further improve the accuracy of biopsies to determine tumour histology. Molecular and genetic analysis of biopsy specimens have the potential to provide additional information to support patient counselling and treatment decision making.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Volpe A, Finelli A, Gill IS, Jewett MA, Martignoni G, Polascik TJ et al (2012) Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol 62:491–504

    Article  PubMed  Google Scholar 

  2. Sahni VA, Ly A, Silverman SG (2011) Usefulness of percutaneous biopsy in diagnosing benign renal masses that mimic malignancy. Abdom Imaging 36:91–101

    Article  PubMed  Google Scholar 

  3. Tsivian M, Mouraviev V, Albala DM, Caso JR, Robertson CN, Madden JF et al (2011) Clinical predictors of renal mass pathological features. BJU Int 107:735–740

    Article  PubMed  Google Scholar 

  4. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H (2003) Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170:2217–2220

    Article  PubMed  Google Scholar 

  5. Choudhary S, Rajesh A, Mayer NJ, Mulcahy KA, Haroon A (2009) Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol 64:517–522

    Article  CAS  PubMed  Google Scholar 

  6. Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol 195:W421–W427

    Article  PubMed  Google Scholar 

  7. Kim JK, Park SY, Shon JH, Cho KS (2004) Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology 230:677–684

    Article  PubMed  Google Scholar 

  8. Remzi M, Katzenbeisser D, Waldert M, Klingler HC, Susani M, Memarsadeghi M et al (2007) Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small. BJU Int 99:1002–1006

    Article  PubMed  Google Scholar 

  9. Jewett MA, Mattar K, Basiuk J, Morash CG, Pautler SE, Siemens DR et al (2011) Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 60:39–44

    Article  PubMed  Google Scholar 

  10. Smaldone MC, Kutikov A, Egleston BL, Canter DJ, Viterbo R, Chen DY et al (2012) Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 118:997–1006

    Article  PubMed  Google Scholar 

  11. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK (2007) Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis. Cancer 109:1763–1768

    Article  PubMed  Google Scholar 

  12. Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924

    Article  PubMed  Google Scholar 

  13. Klingler HC, Marberger M, Mauermann J, Remzi M, Susani M (2007) ‘Skipping’ is still a problem with radiofrequency ablation of small renal tumours. BJU Int 99:998–1001

    Article  PubMed  Google Scholar 

  14. Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al (2013) Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol 190:407–416

    Article  PubMed  Google Scholar 

  15. Shuch B, Said J, La Rochelle JC, Zhou Y, Li G, Klatte T et al (2009) Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology – is up-front resection indicated, and if not, is it avoidable? J Urol 182:2164–2171

    Article  PubMed  PubMed Central  Google Scholar 

  16. Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E et al (2010) Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment. J Urol 184:1877–1881

    Article  PubMed  PubMed Central  Google Scholar 

  17. Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM et al (2013) Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol 31:181–186

    Article  CAS  PubMed  Google Scholar 

  18. Koh Y, Lim HY, Ahn JH, Lee JL, Rha SY, Kim YJ et al (2013) Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma. Ann Oncol 24:1026–1031

    Article  CAS  PubMed  Google Scholar 

  19. Volpe A, Mattar K, Finelli A, Kachura JR, Evans AJ, Geddie WR et al (2008) Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol 180:2333–2337

    Article  PubMed  Google Scholar 

  20. Leveridge MJ, Finelli A, Kachura JR, Evans A, Chung H, Shiff DA et al (2011) Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 60:578–584

    Article  PubMed  Google Scholar 

  21. Wunderlich H, Hindermann W, Al Mustafa AM, Reichelt O, Junker K, Schubert J (2005) The accuracy of 250 fine needle biopsies of renal tumors. J Urol 174:44–46

    Article  PubMed  Google Scholar 

  22. Volpe A, Jewett MA (2009) Current role, techniques and outcomes of percutaneous biopsy of renal tumors. Expert Rev Anticancer Ther 9:773–783

    Article  PubMed  Google Scholar 

  23. Mullins JK, Rodriguez R (2013) Renal cell carcinoma seeding of a percutaneous biopsy tract. Can Urol Assoc J 7:E176–E179

    Article  PubMed  PubMed Central  Google Scholar 

  24. Hopper KD, Yakes WF (1990) The posterior intercostal approach for percutaneous renal procedures: risk of puncturing the lung, spleen, and liver as determined by CT. AJR Am J Roentgenol 154:115–117

    Article  CAS  PubMed  Google Scholar 

  25. Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, Norrie J, Bex A, Bensalah K, Canfield SE, Hora M, Kuczyk MA, Merseburger AS, Mulders PF, Powles T, Staehler M, Ljungberg B, Volpe A (2016) Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol 69(4):660–673. doi:10.1016/j.eururo.2015.07.072

    Article  PubMed  Google Scholar 

  26. Parks GE, Perkins LA, Zagoria RJ, Garvin AJ, Sirintrapun SJ, Geisinger KR (2011) Benefits of a combined approach to sampling of renal neoplasms as demonstrated in a series of 351 cases. Am J Surg Pathol 35:827–835

    Article  PubMed  Google Scholar 

  27. Wood BJ, Khan MA, McGovern F, Harisinghani M, Hahn PF, Mueller PR (1999) Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J Urol 161:1470–1474

    Article  CAS  PubMed  Google Scholar 

  28. Waldert M, Klatte T, Haitel A, Ozsoy M, Schmidbauer J, Marberger M et al (2010) Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol 57:661–665

    Article  PubMed  Google Scholar 

  29. Kummerlin I, ten Kate F, Smedts F, Horn T, Algaba F, Trias I et al (2008) Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability. Eur Urol 53:1219–1225

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alessandro Volpe MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Volpe, A., Zegna, L. (2017). Interventional Ultrasound: Biopsy of Renal Masses. In: Martino, P., Galosi, A. (eds) Atlas of Ultrasonography in Urology, Andrology, and Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-319-40782-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-40782-1_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-40780-7

  • Online ISBN: 978-3-319-40782-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics